New hope for frail myeloma patients: gentler combo aims to control cancer longer
NCT ID NCT03993912
Summary
This study is testing whether adding a newer drug (daratumumab) to a standard treatment (lenalidomide) works better and is easier to tolerate than the current standard for frail, older adults with newly diagnosed multiple myeloma. The goal is to help control the cancer for a longer time without it getting worse, while possibly causing fewer severe side effects. It is for patients who are not healthy enough for the most intensive chemotherapy treatments.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MULTIPLE MYELOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Centre Hospitalier Saint-Malo
St-Malo, France
-
Centre Hospitalier de Perigueux
Périgueux, France
-
Centre Hospitalier de Saint Quentin
Saint-Quentin, France
-
Ch Blois Simone Veil
Blois, France
-
Ch Chartres Louis Pasteur-Le Coudray
Le Coudray, France
-
Ch Fleyriat
Bourg-en-Bresse, France
-
Chi Mont de Marsan Et Pays Des Sources
Mont-de-Marsan, France
-
Chru Brest Site Hopital Morvan
Brest, France
-
Chru Jean Minjoz
Besançon, France
-
Chru Rennes Site Pontchaillou
Rennes, France
-
Chu Dijon Bourgogne
Dijon, France
-
Chu Montpellier
Montpellier, France
-
Chu de Caen Normandie
Caen, France
-
Chu de Grenoble
Grenoble, France
-
Chu de Nantes Site Hotel Dieu Hme
Nantes, France
-
Chu de Nice Hopital de L'Archet
Nice, France
-
Chu de Tours
Tours, France
-
Gpe Hospitalier La Rochelle-Re-Aunis
La Rochelle, France
-
Hopital Haut-Leveque - Chu
Pessac, 33604, France
-
Hopital Prive Sevigne - Cesson
Cesson-Sévigné, France
-
Hôpital Claude Huriez, CHU
Lille, France
-
Institut Paoli Calmettes
Marseille, France
-
Oncopole Chu Toulouse
Toulouse, France
Conditions
Explore the condition pages connected to this study.